Markus Warmuth - President & CEO, Director at Monte Rosa Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
GLUE on Nasdaq
All Insider Reports
All Insider Reports

Markus Warmuth - trading volume in the past year for Monte Rosa Therapeutics, Inc.

Holdings reported by Markus Warmuth for Monte Rosa Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 618,937 $15,209,510 $24.57 07 Jan 2026 Direct
Stock Option (Right to Buy) 406,000 02 Jan 2026 Direct Common Stock

Transactions reported by Markus Warmuth for Monte Rosa Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.